Skip to main content

Spectrum: Autism Research News

topic /

Treatments

Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.

October 2012

Stem cell study identifies early issues in Rett syndrome

by  /  17 October 2012

Neural stem cells derived from people with Rett syndrome show early signs of dysfunction, according to unpublished research presented at the 2012 Society for Neuroscience annual meeting.

Comments

Social molecule disrupted in autism mouse model

by  /  17 October 2012

Mice missing the autism-linked gene CNTNAP2 have broad defects in their oxytocin system, according to research presented Tuesday at the Society for Neuroscience annual meeting in New Orleans. Treatment with oxytocin alleviates social deficits in these mice.

Comments
Statin pills in a blisterpack on a couch.

Cholesterol drug may treat fragile X syndrome

by  /  17 October 2012

A cholesterol-lowering drug called lovastatin prevents seizures in mice that model fragile X syndrome, according to a poster presented Sunday at the 2012 Society for Neuroscience annual meeting in New Orleans.

Comments

Probiotic curbs autism features in mouse model

by  /  16 October 2012

Treatment with a single bacterial species curbs anxiety and repetitive behaviors and boosts vocalizations in a mouse model of autism, according to a poster presented Monday at the 2012 Society for Neuroscience annual meeting in New Orleans.

Comments

Helpful hurdles

by ,  /  16 October 2012

Rapid progress in gene discovery and an emerging map of the molecular landscape of normal brain development are presenting unprecedented opportunities to unravel the biology of autism spectrum disorders, say Matthew State and Nenad Sestan.

Comments

Mouse studies point out limits of Rett syndrome treatment

by  /  15 October 2012

Mouse studies of a promising treatment for Rett syndrome, already in clinical trials, offer a note of caution about the drug’s potential. Preliminary findings from the research, presented Sunday at the Society for Neuroscience annual meeting in New Orleans, show why mouse work remains important even after clinical trials are underway.

Comments

New high-throughput method screens drugs for fragile X

by  /  15 October 2012

Researchers are testing a wealth of new treatments for fragile X syndrome, an inherited intellectual disability often accompanied by autism. They presented preliminary results from animal studies of several drugs, as well as an automated approach for screening compounds, Sunday at the 2012 Society for Neuroscience annual meeting in New Orleans.

Comments

Valium boosts sound-touch integration in autism mouse model

by  /  15 October 2012

The anxiety drug diazepam, commonly marketed as Valium, reverses deficits in sensory integration in a mouse model of autism, according to research presented Sunday at the Society for Neuroscience annual meeting in New Orleans.

Comments

Anxiety drug enhances brain connections in autism

by  /  14 October 2012

A small pilot study suggests that the drug propranolol, typically used to treat hypertension and anxiety, enhances functional connectivity between brain regions and improves verbal fluency, according to research presented Saturday at the 2012 Society for Neuroscience annual meeting in New Orleans.

Comments

Video: Connecting astrocytes to autism

by  /  13 October 2012

Star-shaped cells in the brain wrap themselves around synapses, the junctions between neurons, and influence their development. In a video interview Saturday at the 2012 Society for Neuroscience annual meeting in New Orleans, Ben Barres discusses the possible role of astrocytes in autism.

Comments